Multiple Cerebral Lesions Complicating Therapy with Interleukin-2
Neurol 47:417-424, Karp,B.I.,et al, 1996
Side Effect Profile of Interferon Beta-1b in MS:Results of an Open Label Trial
Neurol 46:552-554, Neilley,L.K.,et al, 1996
Chronic Lymphocytic Leukemia and the Central Nervous System:A clinical and Pathological Study
Neurol 46:19-25, Cramer,S.C.,et al, 1996
Intermittent Cyclophosphamide & Prednisone Trtm of Polyneuropathy Assoc with Monocl Gamopathy of Undeter Sign
Neurol 47:1227-1233, Notermans,N.C.,et al, 1996
Selegiline and Mortality in Parkinson's Disease
Ann Neurol 40:841-845, Olanow,C.W.,et al, 1996
Routine Indomethacin Prophylaxis:Has the Time Come
Pediatrics 98:784-785, Bada,H.S., 1996
Intraarterial Thrombolysis in Vertebrobasilar Occlusion
AJNR 17:255-262, Becker,K.J.,et al, 1996
Concern About Safety of Carotid Angioplasty
Stroke 27:197-198, Beebe,H.G.,et al, 1996
Lubeluzole in Acute Ischemic Stroke:A Double-Blind Placebo-Controlled Phase II Trial
Stroke 27:76-81, Diener,H.C.,et al, 1996
Management of Patients Receiving Interferon Beta-1b for MS:Report of a Consensus Conf
Neurol 46:12-18, Lublin,F.D.,et al, 1996
Exacerbation of Myasthenia Gravis Associated with Cocaine Use
Neurol 46:271-272, Daras,M.,et al, 1996
Acute Meningitis with a Negative Gram's Stain:Clinical and Management Outcomes in 171 Episodes
Am J Med 100:78-84, Elmore,J.G.,et al, 1996
Meningitis, Vasculitis, and Cerebritis Caused by CNS Histoplasmosis:Radiologic-Pathologic Correlation
AJR 166:194-196, Zalduondo,F.M.,et al, 1996
Impact of Deprenyl and Toxopherol Treatment on Parkinson's Disease in DATATOP Subjects Not Requiring Levodopa
Parkinson Study Group, Ann Neurol 39:29-361996., , 1996
Impact of Deprenyl and Toxopherol Treatment on Parkinson's Disease in DATATOP Patients Requiring Levodopa
Parkinson Study Group, Ann Neurol 39:37-451996., , 1996
Prognostic Value of the Hyperdense Middle Cerebral Artery Sign and Stroke Scale Score Before Ultraearly Thrombolytic Therapy
AJNR 17:79-85, Tomsick,T.,et al, 1996
Reduction in Carotid Arterial Wall Thickness Using Lovastatin & Dietary Therapy
Ann Int Med 124:548-556, Hodis,H.N.,et al, 1996
Hemorrhagic Transfor of Brain Infarct:Predictability in First 5 hrs. From Stroke Onset & Influ on Clin Outcome
Neurol 46:341-345, Toni,D.,et al, 1996
The Relation Between Fish Consump & Stroke Incidence, NHANES I Epidemiol Study
Arch Int Med 156:537-542, Gillum,R.F.,et al, 1996
Trimethoprim and Sulfonamide-Associated Meningoencephalitis with MRI Correlates
Neurol 46:556-558, Blumenfeld,H.,et al, 1996
Optic Neuropathy
Neurol 46:315-322, Newman,N.J., 1996
A 60-Year-Old Man with Parkinson's Disease
JAMA 275:716-722, Olanow,C.W., 1996
Cognitive Impairment & Mortality in a Cohort of Elderly People
BMJ 312:608-611, Gale,C.R.,et al, 1996
Brain Death:MR and MR Angiography
AJNR 17:731-735, Ishii,K.,et al, 1996
The Value of Intracranial Pressure Monitoring in Acute Hemispheric Stroke
Neurol 47:393-398, Schwab,S.,et al, 1996
Intra-Arterial Thrombolysis in Acute Ischaemic Stroke:Experience with a Superselective Catheter Embedded in the Clot
JNNP 60:667-670, Castro,L.,et al, 1996
Thrombolytic Therapy of Acute Basilar Artery Occlusion-Variables Affecting Recanalization and Outcome
Stroke 27:875-881, Brandt,T.,et al, 1996
Open Trial of I. V. Tissue Plasminogen Activator in Acute Carotid Territory Stroke-Correl of Outcome with Clin & Radiol Data
Stroke 27:882-890, Trouillas,P.,et al, 1996
Thrombolytic Therapy with Streptokinase in Acute Ischemic Stroke
The MAST-E Study Group, NEJM 335:145-1501996., , 1996
Thrombolytic Therapy for Acute Ischemic Stroke-Summary Statement
Report of the Quality Standards Subcommittee of the AAN, Neurol 47:835-8391996., , 1996
Dietary Flavonoids, Antioxidant Vitamins, and Incidence of Stroke
Arch Int Med 154:637-642, Keli,S.O.,et al, 1996
'Malignant'Middle Cerebral Artery Territory Infarction
Arch Neurol 53:309-315, Macke,W.,et al, 1996
Chorea Caused by Lithium Intoxication
Mov Disord 11:733-737, Podskalny, G.D. & Factor, S.A., 1996
Brain Edema after Carotid Surgery
Neurol 46:175-181, Breen, J.C.,et al, 1996
Reversible Dementia and Apparent Brain Atrophy During Valproate Therapy
Ann Neurol 38:687-691, Papazian,O.,et al, 1995
The Effect of Deprenyl and Levodopa on the Progression of Parkinson's Disease
Ann Neurol 38:771-777, Olanow,C.W.,et al, 1995
Comparison of Therapeutic Effects & Mortality Data of Levodopa & Levodopa with Selegiline in Pts with Early, Mild Parkinson's
BMJ 311:1602-1607, 15831995., Lee,A.J.,et al, 1995
The Effect of Comb Oral Lysine Acetylsalicylate & Metoclopramide Compared w/Oral Sumatriptan for Migraine
Lancet 346:923-926, Tfelt-Hansen,P.,et al, 1995
Myasthenic Symptoms in Patients with Mitochondrial Myopathies
Muscle & Nerve 18:1338-1340995., Forestier,N.L.,et al, 1995
Chronic Inflammatory Demyelinating Polyneuropathy Complicating Liver Transplantation
Ann Neurol 38:828-831, Taylor,B.V.,et al, 1995
Increased Incidence of Levodopa Therapy Following Metoclopramide Use
JAMA 274:1780-1782, Avorn,J.,et al, 1995
Neurological Correlated of Fetal Cocaine Exposure:Transient Hypertonia of Infancy and Early Childhood
Pediatrics 96:1070-1077, Chiriboga,C.A.,et al, 1995
Benign Intracranial Hypertension in Children with Growth Hormone Deficiency Treated with Growth Hormone
J Pediatr 126:996-999, Malozowski,S.,et al, 1995
Interventional Neuroradiology
BMJ 311:789-792, Taylor,W.&Rodesch,G., 1995
The Natural History of Progressive Mutlifocal Leukoencephalopathy in Patients with AIDS
Clin Inf Dis 20:1305-1310, Fong,I.W.,et al, 1995
Digitalis-Induced Visual Disturbances with Therapeutic Serum Digitalis Concentrations
Ann Int Med 123:676-680, Butler,V.P.,et al, 1995
Thrombolytic Therapy in Acute Occlusion of the Intracranial Internal Carotid Artery Bifurcation
AJNR 16:1977-1986, 19941995., Jansen,O.,et al, 1995
Cost-effectiveness of Emergency Intraarterial Intracerebral Thrombolysis:A Pilot Study
AJNR 16:1987-1993, 19941995., Lanzieri,C.F.,et al, 1995
Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator for Acute Hemispheric Stroke:The ECASS
JAMA 274:1017-1025, 10581995., Hacke,W.,et al, 1995
Tissue Plasminogen Activator for Acute Ischemic Stroke
National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group, NEJM 333:1581-1587, 12,1995., 1995